Creative Planning - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,211
-57.0%
13,690
-6.8%
0.00%
Q2 2023$19,097
-64.1%
14,690
-51.4%
0.00%
Q1 2023$53,166
+5.6%
30,208
+88.3%
0.00%
Q4 2022$50,366
-31.0%
16,040
+7.1%
0.00%
Q3 2022$73,000
+19.7%
14,979
+0.9%
0.00%
Q2 2022$61,000
-29.1%
14,8400.0%0.00%
Q1 2022$86,000
-29.5%
14,840
-8.8%
0.00%
Q4 2021$122,000
-12.9%
16,269
+4.4%
0.00%
Q3 2021$140,000
-14.6%
15,590
+13.9%
0.00%
Q2 2021$164,000
-17.2%
13,690
-13.5%
0.00%
Q1 2021$198,000
-19.8%
15,8200.0%0.00%
-100.0%
Q4 2020$247,000
+65.8%
15,8200.0%0.00%
Q3 2020$149,000
+10.4%
15,820
+4.6%
0.00%
Q2 2020$135,000
-83.9%
15,120
-88.6%
0.00%
-100.0%
Q1 2020$840,000
-77.1%
132,133
-69.9%
0.00%
-72.7%
Q4 2019$3,669,000
+972.8%
438,382
+1058.9%
0.01%
+1000.0%
Q3 2019$342,000
-42.3%
37,829
-31.3%
0.00%
-50.0%
Q2 2019$593,000
+115.6%
55,104
+91.1%
0.00%
+100.0%
Q1 2019$275,000
+3.0%
28,839
+23.9%
0.00%0.0%
Q4 2018$267,000
-53.1%
23,284
-30.7%
0.00%
-50.0%
Q3 2018$569,000
+31.7%
33,584
+10.4%
0.00%0.0%
Q2 2018$432,000
+118.2%
30,413
+192.1%
0.00%
+100.0%
Q1 2018$198,000
+607.1%
10,413
+232.5%
0.00%
Q2 2017$28,000
+460.0%
3,132
+213.2%
0.00%
Q1 2017$5,000
-28.6%
1,000
-33.3%
0.00%
Q3 2016$7,000
+75.0%
1,500
+275.0%
0.00%
Q3 2013$4,0004000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders